NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

骨關節炎治療藥的全球市場:產業趨勢,市場佔有率·規模·成長率·機會及預測(2020年∼2025年)

Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版商 IMARC Services Private Limited 商品編碼 976000
出版日期 內容資訊 英文 143 Pages
商品交期: 2-3個工作天內
價格
骨關節炎治療藥的全球市場:產業趨勢,市場佔有率·規模·成長率·機會及預測(2020年∼2025年) Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日期: 2020年12月05日內容資訊: 英文 143 Pages
簡介

2014-2019年期間,全球骨關節炎治療市場的複合年增長率約為8%。久坐的生活方式,不健康的飲食習慣以及肥胖和血糖的升高正在增加個體發生OA的風險,加上越來越多的老年人群體(更容易患此類疾病),是促使老年人發病的關鍵因素之一。除此之外,易於獲取的MRI掃描是另一個主要的增長誘因,基於放射學特徵的成像生物標誌物的發展以及止痛藥的引入,也為市場增長做出了貢獻。展望未來,預計全球骨關節炎治療藥物市場在未來五年將繼續保持溫和增長。。

本報告提供全球骨關節炎治療藥市場的相關調查,提供產業趨勢,市場預測,人體的部位·藥物類型·給藥途徑·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 範圍和調查方法

第3章 摘要整理

第4章 簡介

第5章 全球骨關節炎治療藥市場

  • 市場概要
  • 市場實際成果
  • COVID-19的影響

第6章 各人體的部位市場區隔

  • 髖關節
  • 脊椎
  • 其他

第7章 各藥物類型市場區隔

  • 非類固醇消炎劑
  • 止痛藥
  • 皮質類固醇
  • 其他

第8章 各給藥途徑的市場區隔

  • 非口服
  • 局部
  • 口服

第9章 各終端用戶市場區隔

  • 醫院
  • 專門診所
  • 醫療機關
  • 其他

第10章 各地區的市場區隔

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東·非洲
    • 各國市場區隔

第11章 SWOT分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 價格分析

第15章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Abbott Laboratories
    • Anika Therapeutics Inc.
    • Bayer Aktiengesellschaft
    • Eli Lilly and Company
    • Flexion Therapeutics Inc.
    • GlaxoSmithKline Plc
    • Horizon Therapeutics Plc
    • Johnson & Johnson Inc.
    • Pfizer Inc.
    • Sanofi S.A
目錄
Product Code: SR1019O91_Report

The global osteoarthritis therapeutics market grew at a CAGR of around 8% during 2014-2019. Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown. Looking forward, IMARC Group expects the global osteoarthritis therapeutics market to continue its moderate growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoarthritis therapeutics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, anatomy type, drug type, route of administration and end user.

Breakup by Anatomy Type:

  • Knee
  • Hip
  • Hand
  • Spine
  • Others

Breakup by Drug Type:

  • Nonsteroidal Anti-Inflammatory Drugs
  • Analgesics
  • Corticosteroids
  • Others

Breakup by Route of Administration:

  • Parenteral
  • Topical
  • Oral

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Medical Institutions
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:

  • How has the global osteoarthritis therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the anatomy type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global osteoarthritis therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Anatomy Type

  • 6.1 Knee
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hand
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Spine
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Nonsteroidal Anti-Inflammatory Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Analgesics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Corticosteroids
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Parenteral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Topical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oral
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Institutions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eli Lilly and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Flexion Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GlaxoSmithKline Plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Horizon Therapeutics Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2019
  • Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2019
  • Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2019
  • Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by End User (in %), 2019
  • Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million US$), 2014 & 2019

Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million US$), 2020-2025

  • Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Osteoarthritis Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Osteoarthritis Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
  • Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
  • Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million US$), 2020-2025
  • Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2020-2025
  • Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
  • Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by End User (in Million US$), 2020-2025
  • Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Osteoarthritis Therapeutics Market Structure
  • Table 8: Global: Osteoarthritis Therapeutics Market: Key Players